The Ministry of Health, via its Chemistry, Food and Drug Division, has announced a voluntary recall affecting specific lots of bisoprolol fumarate and hydrochlorothiazide tablets, a generic medication used to treat hypertension.

The affected lots are 17232401 (expiring November 2025), 17232401 (expiring November 2025), 17232401 (expiring November 2025), 17240974 (expiring May 2026), 17240974 (expiring May 2026) and 17240974 (expiring May 2026).

The recall was initiated by Glenmark Pharmaceuticals Inc in coordination with the US Food and Drug Administration (FDA) after routine quality testing identified a potential cross-contamination issue. Trace amounts of another drug, ezetimibe, a medication used to treat high cholesterol, were detected in reserve samples of the product, which should not have been present in the blood-pressure medication.